Company / Assets per Share
Corvus Pharmaceuticals, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.13
FY2024
5-year range
$0.95 / $2.90
FY2020-FY2024
Trend
+19.1%
vs FY2023
Sector context
#197 of 212
Health Care
What the data says
Among 212 Health Care companies, Corvus Pharmaceuticals, Inc. is in the bottom 7% for assets per share. Assets per Share returned to growth in FY2024 after 3 years of decline, reaching $1.13.
Based on SEC 10-K filings.
1.13 in FY2024 with a 5-year CAGR of -16.9%.
Declined from $1.47 to $1.13 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -24.4%
- 5-Year CAGR
- -16.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 212This company $1.13 Sector average $294.36
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 19.1% year-over-year.
- Ranks #197 out of 212 companies in the Health Care sector.
- Peak assets per share was recorded in FY2015.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.13 | +19.1% |
| FY2023 | $0.95 | -35.3% |
| FY2022 | $1.47 | -43.9% |
| FY2021 | $2.62 | -9.9% |
| FY2020 | $2.90 | +1.8% |
| FY2019 | $2.85 | -33.7% |
| FY2018 | $4.30 | -7.1% |
| FY2017 | $4.63 | -49.1% |
| FY2016 | $9.09 | -96.6% |
| FY2015 | $263.51 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026